FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

35086111000001103: Canakinumab 150mg/1ml solution for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Feb 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
106264201000001119 Canakinumab 150mg/1ml solution for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
106264301000001111 Canakinumab 150mg/1ml solution for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Canakinumab 150mg/1ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninjection.subcutaneous ontology form and route true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Subcutaneous route true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Is a Canakinumab true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Is a Product containing canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has active ingredient Canakinumab false Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Has specific active ingredient Canakinumab true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ilaris 150mg/1ml solution for injection vials (Novartis Pharmaceuticals UK Ltd) Is a True Canakinumab 150mg/1ml solution for injection vials Inferred relationship Existential restriction modifier
Canakinumab 150mg/1ml solution for injection vials 1 vial Has VMP True Canakinumab 150mg/1ml solution for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start